At Ulysses Neuroscience Ltd. we are experts in creating a relationship of trust and collaboration with clinicians and patient communities. We organise initiatives such as awareness days and focus groups that provide great insight into the needs and wishes of both the patient and caregiver community and that of their clinicians.
We have a strong working relationship with local and international clinical sites and have robust protocols to ensure the highest standard of quality from sample collection through to analysis. From bedside to bench, we integrate this information into the design of bespoke biomarker and target identification studies and phase IV trials.
Specialising in fluid biomarker analysis in conjunction with existing clinical assessments and scales, we advance the understanding of druggable targets and epidemiological characteristics of a disorder alongside the patient and caregiver populations, and help pharmaceutical companies improve their reach and study efficacy.